Abstract
Objective
Low resting metabolic rate (RMR), as a risk factor for weight gain and obesity, can be influenced by many factors. Empirical research has confirmed the role of appetite and related hormones in obesity and energy intake. This study aimed to investigate the relationship between appetite and related hormones in overweight or obese Iranian women with normal and hypo RMR.
Methods
This case–control study was conducted on 42 Iranian adult women (21 cases, and 21 controls), aged 18–48 years. An impedance body analyzer was used to obtain the body composition and an indirect calorimeter was used to assess the RMR. The Flint questionnaire was used to assess appetite, dietary intake, and physical activity were assessed by FFQ and IPAQ questionnaires respectively, and ELISA kits were used to assess leptin, ghrelin, and insulin hormones.
Results
The results of the study demonstrated a negative association between ghrelin hormone level (β = -0.34, 95%CI = -61.70,-3.86, P-value = 0.027) and RMR, and a positive association between insulin hormone level (β = 0.48, 95%CI = 9.38–34.35, P-value = 0.001) and RMR. Also, results of the appetite questionnaire showed that, in general, both appetite (β = 0.32, 95%CI = -0.10–2.99 P-value = 0.044) and hunger variable (β = 0.30, 95%CI = 0.04–5.87, P-value = 0.047) have a positive association with RMR. There was no significant association between leptin levels and RMR.
Conclusion
It is evident that appetite and related hormones have a potential role in promoting a normal RMR.
Similar content being viewed by others
Introduction
Obesity is one of the most important health problems in the last century, and whilst its incidence continues to rise [1]. The etiology of obesity is multifactorial and is generally caused by an imbalance between energy intake and energy expenditure [2]. In general, total daily energy expenditure consists of three main components [3], and resting metabolic rate (RMR) accounts for the largest share of total daily energy requirements (approximately 60 to 75%). Numerous factors affect the level of RMR, including age, sex, race, size, body composition, and hormonal status [4,5,6,7,8]. Studies have shown that RMR is an important determinant of meal size and energy intake per day and reflects the physiological need for food intake [9, 10], and is posited as a predictor of fasting hunger, affecting the overall hunger profile [11].
The brain regulates energy homeostasis through neuropeptide signals from adipose tissue and the gastrointestinal tract; for this reason, the gastrointestinal tract is one of the main components of the food and appetite control system [12]. Many intestinal peptides, including ghrelin, are secreted in this pathway [13]. Ghrelin circulates in two forms: Acylated ghrelin (AG) that has orexigenic, obesogenic, diabetogenic features [14, 15], and Unacylated ghrelin (UAG) that has been demonstrated to inhibit these effects [16,17,18,19]. Systemic levels of ghrelin in the blood plasma are increased before eating and its secretion is stimulated and enhanced during calorie restriction [20,21,22,23]; ghrelin, therefore, plays a role in controlling energy balance, increasing food intake, and reducing energy consumption [24].
The Insulin and Leptin hormones, balance food intake and energy expenditure. Their circulating levels are associated with body fat content [25]. They affect the central nervous system especially the hypothalamus in proportion to their plasma levels where they act to reduce energy intake and stimulate energy expenditure through the leptin receptor [25,26,27].
Several studies demonstrated the associations between leptin and RMR when adjusting for body composition. Two of these controlled for fat-free mass (FFM), one of them reported a correlation in women but not in men [28], whereas the other found leptin to be correlated to RMR in men only [29]. The third study controlled for fat mass (FM), age, and sex and found an inverse association between leptin and RMR. However, other studies found no significant associations between leptin and RMR [30,31,32,33]. Caudwell et al. demonstrated that RMR was a strong determinant of daily hunger, self-selected meal size, and daily energy intake in overweight and obese individuals [9], while Westerterp-Plantenga et al. noted a negative association between RMR and meal frequency in young men [34]. Furthermore, the findings of Johnson, K.O. et al. imply that RMR does not influence appetite [35].
Nonetheless, the relationship between appetite and related hormones with RMR requires further investigation. As studies have yielded conflicting results and did not assess the association in stratified RMR groups. Moreover, they did not evaluate appetite sensation, physical activity, and dietary intakes (micronutrients, macronutrients, and food groups). Thus, we sought to discern whether appetite and hormones differed in overweight/obese women with normal RMR and hypo RMR. To the best of our knowledge, this is the first study of its kind in this field.
Methods
Study population, sampling procedures
We conducted a case–control study and enrolled 42 women from Tehran (21 cases and 21 controls), matched for age and BMI, who had been referred to a nutritional laboratory from September 2019 to January 2019. The sample size was determined to recognize the difference of 2 ng (µ1-µ2=2) between the case and control groups in the Type I error α = 0.05 and the power of 1-β = 0.90. According to a study by Marzullo and colleagues [36], the standard deviation for ghrelin was determined to be 2. Using the above descriptive, the sample size of 21 was calculated, which implied we needed to recruit 21 participants in each group.
We designed a Telegram bot, and 1300 volunteers were signed up. Participants were asked to fill out the initial online questionnaire to find out whether they have the basic criteria for inclusion in the study. Out of 1300 volunteers registered, 122 people were eligible samples, and finally, after assessing their medical history, 85 people met the final conditions for study entry (Figure 1). In a monitoring period of 2–3 months, the subjects were followed by phone call to make sure that, they don’t follow special diets and not experiencing weight fluctuations or not participating in any professional sport, to coordinate and control the physical activity we recommended to all participants to keep 20 min of moderate physical activity that is available to everyone and we inquired it by phone call. Also, participants were monitored in terms of consumption of alcohol, drugs, and supplements that affect the rate of metabolism and related hormones. After a follow-up period, 47 individuals were referred to the Nutrition Laboratory of the Faculty of Nutrition and Dietetics located at the School of Health of Tehran University of Medical Sciences for more detailed evaluations. Each person in the case group (low metabolism) was randomly matched with a person in the control group (normal metabolism) with a maximum difference in age ± 2 years and body mass index ± 2 units. Volunteers were randomly selected for the study based on the following inclusion criteria (for both cases and controls): Female gender, 25 ≤ BMI < 40 (obesity and overweight), age over 18 to 50 years, willingness to participate in the study. To ensure comparable data, participants who met any of the following exclusion criteria were excluded: having cardiovascular disease, liver, kidney, thyroid, cancer, diabetes, heart failure, and acute or chronic infections based on patient statements and medical history, consumption of drugs and supplements that affect the rate of metabolism, pregnant, lactating, postmenopausal women and professional athletes, history of weight loss surgeries, history of weight loss diet and weight changes during the last 6 months, drug and alcohol use, following special diets, and reluctance to continue. Participants were told that they could withdraw themselves or their data from the study at any time.
The study protocol was approved by the ethics committee of Tehran University of Medical Sciences (ethics code: (IR.TUMS.MEDICINE.REC.1399.261), and all subjects signed written informed consent prior to participation.
Measurements
Resting metabolic rate
In this study, RMR was measured by indirect calorimetry (MetaLyzer 3B-R3 Cortex Biophysik GmbH spirometer, Germany) [37]. Ventilation and gas exchange were calibrated for each individual before each experiment, and the amount of carbon dioxide produced and oxygen consumed per breath was recorded. In this study, a respiratory mask was used, respiratory volume was transferred through a transducer attached to the mask, and gas samples were collected. Resting metabolic rate was assessed in the early morning and after 10 to 12 h of fasting. Participants were asked to refrain from consuming caffeine and exercising vigorously for 24 h before the test. Subjects were tested in the follicular phase of the menstrual cycle, because during the luteal phase of the menstrual cycle, RMR normally rises and is lower during menstruation [38, 39]. The measurements were taken with the patients lying down in a supine position for30 minutes; where the middle 20 min were used for analyses (the first and the last 5 min were ignored). The room was kept at a constant temperature of 22 degrees Celsius, and the validation of this device has been confirmed by several studies [40, 41]. Out of 47 participants who underwent the RMR test, a total of 21 patients were in the case group and 21 patients were in the control group. Three patients with low RMR (case group) and 2 patients with normal RMR (control group) were excluded from the study because they remained unmatched. The criterion for determining low RMR in this study is based on Flancbaum et al. [42], where subjects were defined as “hypometabolic” when their measured RMR was less than 85% of the predicted RMR, based on the Harris and Benedict equation, or “normometabolic” when it was within ± 15% of the predicted RMR. PRMR was also calculated based on the formula of Harris-Benedict [43].
Predicted RMR (Harris-Benedict) = 665 + 9.56 × weight (kg) + 1.84 × height (cm) – 4.67 × age (year).
Body composition
Body composition, including weight, body mass index (BMI), body fat mass (BFM), fat-free mass (FFM), visceral fat level, visceral fat area, skeletal muscle mass, body fat percentage (PBF%), waist to hip ratio (WHR), waist circumference (WC), and soft lean mass were obtained using a body composition analyzer [44]. To measure the body composition of all participants, in a fasted state, the body analyzer InBody 770 scanner (Inbody Co., Seoul, Korea) was used. Before measurement, according to the instructions of the manufacturer, all participants were asked to remove any metallic objects (e.g., jewelry), and asked to stand barefoot, with minimal clothing, on the metal plate of the device. The operation of the body analyzer was conducted according to the manufacturer's instructions.
Dietary assessments
A person's usual dietary intake over the past year was assessed by interview, using a semi-quantitative, 147-item food frequency questionnaire (FFQ). Based on this questionnaire, the subjects were asked to report the frequency of their food consumption for each food item on a daily, weekly, monthly, or yearly basis. The reliability and validity of this questionnaire in Iranian populations have already been confirmed [45]. Standard unit sizes and items reported on the household measures were converted to grams using the household measures Guide [46]. The energy content of the food items in the food frequency questionnaire was determined using data from the USDA Food Ingredients Table in the Nutritionist 4 nutrition software database.
Physical activity
In order to assess the physical activity of the participants, the short form of the International Physical Activity Questionnaire (IPAQ), designed by the World Health Organization, was used [47]. The validity and reliability of this tool have already been evaluated and shown to be acceptable in Iranian adult women. Scores were calculated according to the frequency and time spent on light, moderate, high, and very high-intensity activities, based on a list of common daily activities.
Appetite
In this study, the Flint appetite questionnaire was used to assess mental feelings about appetite [48]. The validity and reliability of this questionnaire were previously approved [48]. Participants completed the appetite questionnaire in the morning, after the RMR test and body composition analyses (which lasted about 35 min). In this research, four indicators were included; feeling of desire for food, feeling of hunger, feeling of satiety, and feeling of consuming future food. Scoring was conducted in the following manner; participants selected a value from 0 to 100 e.g., I am not hungry at all (zero points), I have not been so hungry so far (100 points). The face validity of the test was checked through questioning the experts of validity [49, 50], and the reliability of the test was ensured through the application of test–retest, reliability (Cronbach Alpha 0.8).
Blood sampling
From all participants, following 12-h overnight fasting, 10 cc of fasting blood was drawn between 7–10 am. After storage for 30 min at room temperature, a blood clot formed and was centrifuged at 3000 g for 20 min. Serums were stored in clean microtubes in a freezer at -80° C until the analysis was performed.
Biochemical and hormonal assessments
All hormones were measured by the enzyme-linked immunosorbent assay (ELISA) method. Leptin levels were assessed with an LDN kit (Nordhorn, Germany), with a sensitivity of 0.50 ng/ml, total ghrelin levels were assessed, with a sensitivity of 0.01 ng/ml with Crystal Day Christian Day kit, China, and insulin levels were assessed with an IBT kit (Infinitum biotech, IBT; Netherland), with a sensitivity of 0.11 μU / ml.
Intra- and inter-assay coefficients of variation (CV) reported by the manufacturer were 3.7– 5% and 5.9–5.8% for leptin, CV < 8%, and CV < 10% for total ghrelin, and 3.7–4.2% and 3.7–4.2% for insulin, respectively.
Statistical analysis
All data were analyzed using SPSS software version 25, where P-values less than 0.05 were, a priori, considered statistically significant. The normality of variable distribution was evaluated using Kolmogorov–Smirnov and Shapiro Wilk tests. Because our data did not show a normal distribution, we used non-parametric tests. The Wilcoxon test was used to determine the difference between quantitative variables between case and control groups. Chi-square test or Fischer exact tests were used to determine the distribution of qualitative variables between case and control groups. Linear regression analysis was used to determine the relationship between appetite and related hormones with RMR, in a crude and adjusted model (adjusted for body fat percentage).
Results
The present study was conducted on 42 obese and overweight Iranian women, of which, 59.5% were married, 69% occupied, 92.8% had a college education and 52.3% had good economic status.
Baseline participant characteristics are presented in (Table 1). The median (IQR) age, weight, BMI, WHR, WC, BFM, FFM were 34.00 (10) years, 77.25 [16] kg, 29.05(5.6) kg/m2, 0.92(0.07), 96.50(14.8) cm, 33.10(12.10) kg, 45.20(7.82) kg. The median age, weight, BMI, WHR, WC, BFM, and FFM were not significantly different among the case and control groups; however, there was a statistically significant difference between the case and control groups in terms of PBF%(P-value = 0.027). Also, the median of measured RMR was significantly higher in controls compared to cases, (median: 1541.00, IQR: 232.50 vs median: 1306.00, IQR: 325.0) (P-value < 0.001).
Based on the test of qualitative variables (such as physical activity) between the case and control groups, there was no significant difference between the two groups (presented in Table 1), in addition to no significant difference in terms of intake of micronutrients, macronutrients and food groups between the two groups (is presented in Table 2).
In Table 3, the median of studied appetite and hormones are presented. The median (IQR) appetite, leptin, ghrelin, and insulin were 225 [75], 20.65(4.68), 1.97(3.58), and 14.38(6.98). Examination of appetite and leptin, ghrelin, and insulin hormones showed no significant difference between the case and control groups (P-value > 0.05).
To discern an association between appetite and related hormones with RMR, we conducted linear regression, using a crude and adjusted model (presented in Table 4). Our crude result indicated that the insulin hormone levels (β = 0.48 95%CI = 9.38,34.35, P-value = 0.001) were positively related to RMR (Fig. 2), and in addition to an inverse association between ghrelin hormone levels (β = -0.34, 95%CI = -61.70,-3.86, P-value = 0.027) and RMR (Fig. 3). After adjusting for body fat percentage, the results remained significant, and, in the adjusted model, there was a positive association between appetite (β = 0.32, 95%CI = -0.10,2.99 P-value = 0.04) and RMR. Appetite questionnaire indices and their relationship with RMR are detailed in Table 5. Accordingly, there was a positive significant relationship between the rate of hunger (β = 0.30, 95%CI = 0.09–5.95, P-value = 0.04) and RMR, which remained significant after adjusting for the confounding variable. We also investigated the association between RMR and related hormones separately in case and control groups. The results showed that there was a negative relationship between serum ghrelin levels and RMR in the “hypometabolic” group (β = -0.50, 95%CI = -0.01,-0.001, P-value = 0.02), after adjusting for PBF%, the results remained significant. While, no association was found between serum ghrelin levels and RMR in the “normometabolic” group (β = -0.12, 95%CI = -0.008,-0.005, P-value = 0.59). However the association between Insulin level and RMR was significant in both “hypometabolic” group (β = 0.61, 95%CI = 8.61–36.43, P-value = 0.003) and “normometabolic” group (β = 0.45, 95%CI = 0.80–32.16, P-value = 0.04. The results remained significant after controlling for PBF%. Although there was no significant difference between dietary intake and the level of physical activity between the case and control groups, we assessed the association between appetite and related hormones while adjusting for the effects of dietary intake and physical activity, however, the results did not change.
Discussion
Our novel approach, including assessing the relationship between stratified RMR groups matching by BMI and age, with both appetite sensation and related hormone levels in a well-characterized case–control study in overweight/obese healthy women., produced data suggesting that there was no significant difference between the median appetite and hormones of leptin, ghrelin, and insulin between the two groups with normal metabolism and impaired metabolism. However, there was a significant positive association between appetite and the rate of hunger with RMR. And also, a positive association between insulin levels with RMR, and a negative association between ghrelin levels with RMR, was found.
We also measured physical activity in the participants. Based on the systematic review and meta-analysis by MacKenzie-Shalders et al., resistance exercise significantly increased RMR when compared to a control group as measured by indirect calorimetry [51]. Physical activity can increase energy expenditure severalfold depending on the volume, mode, and intensity [52]. In our study, however, there was no significant difference in the level of physical activity among the case and control groups, as we coordinate and control it. We also assessed dietary intakes in the study population. Based on previous investigations, adherence to diets lower in carbohydrates and higher in fat and protein were linked with higher RMR [53, 54]. In addition, there was no significant difference in the dietary intakes between the two groups.
The results of the appetite questionnaire indicated a significant direct relationship with RMR. Also, in examining the indicators of the appetite questionnaire [48] with RMR, we found that there was a positive relationship between hunger and RMR, which remained significant after adjusting for the confounding variable, which was concordant with Caudwell et al. [9]. However, Johnson, K.O. et al. findings imply that appetite is linked to FFM rather than RMR [35]. These discrepancies might be due to variations in methodology and design. The obesity paradox highlights that, in people with obesity, despite the higher FM and energy stored in the body (relative to normal-weight individuals), the hunger and the tendency to eat are high [55]; interestingly, it has been posited that, due to the high FM, lean mass (FFM) is also high and FFM is one of the important determinants of RMR [8], and consequently, the higher RMR level corresponds to a higher rate of hunger and appetite [9, 10, 56, 57].
In the present study, the hypothesis that the serum level of leptin hormone is associated with RMR in the study population was not confirmed. There is evidence to suggest that leptin is involved in regulating energy metabolism mainly through its effects on the cardiovascular system and brown adipose tissue thermogenesis via the hypothalamus [58].
However, in our study, there was no difference in leptin between the two groups, and no significant association was observed between this hormone and RMR, which was correspondent with the results of the study by Neuhauser et al.[59]. Human studies examining the relationship between leptin hormone and RMR have yielded conflicting results, some of which have reported no association between RMR and leptin levels in adults [60,61,62], some studies have reported a positive association [28, 29], and some a negative association [63]. One of the reasons for these contradictory results may be attributed to differences in procedure. In studying the relationship between leptin and RMR, body composition, FM, and FFM are important variables that must be considered [64]. While many of the aforementioned studies reported a positive association, they did not consider these variables. In fact, one of the most important determinants of serum leptin is body fat [62, 65] and also, serum leptin concentration is closely associated with BMI [66], thus, in our study, this may explain why no a difference in leptin levels was seen between the two groups.
We found a negative relationship between serum ghrelin levels and RMR in the whole population study. There is empirical evidence to suggest that ghrelin is involved in energy metabolism, especially in regulating food intake [15, 22, 67,68,69,70,71,72,73,74].
Our results indicated a significant inverse relationship of the ghrelin hormone with RMR in the study population, which is congruent with the results of Pierre et al. [75]. Indeed, Pierre et al., investigated the relationship between RMR and ghrelin levels in normal-weight samples and implied that ghrelin may serve as a biomarker of increased energy efficiency (i.e. lower energy expenditure) in humans. The relationship between ghrelin and energy metabolism levels in obese and overweight people evidently needs further investigation [76].
Our analysis conducted separately in stratified RMR groups showed that there is a negative relationship between serum ghrelin levels and RMR only in the “hypometabolic” group. And no association was found between serum ghrelin levels and RMR in the “normometabolic” group. However, Marzullo et al. have shown different results from our research, they suggested that ghrelin secretion is decreased in obesity in cases of impaired energy expenditure [36]. Discrepancies in results might be due to variation in the criterion for determining low RMR and normal RMR. And also Marzullo et al. reported this unexpected association in terms of active ghrelin (Acylated Ghrelin) not total ghrelin level.
One might hypothesize that ghrelin is expected to intervene endogenously to improve impaired energy metabolism. These hypotheses raise the possibility that the metabolic effects of ghrelin may extend beyond the regulation of satiety, food intake, and substrate oxidation, and may play a role to improve energy efficiency in overweight and obese women.
The present study demonstrates that the serum level of insulin hormone is positively associated with RMR in two groups with normal and impaired metabolism, which is concordant with Drabsch et al. and Huang et al. [77, 78]. Homeostatic regulation of glucose is managed through the action of the insulin hormone in adipose tissue, muscle, and liver tissue [79]. In general, one of the main functions of insulin is to focus on tissues that regulate energy metabolism [80].
In fact, the results showed that, the higher the level of insulin hormone, the higher the RMR, which is consistent with Ravussin et al., through the Euglycemic Insulin clamp technique the thermic effect of insulin and glucose injection can be studied in detail [81]. The physiological mechanisms responsible for the relationship between RMR and Insulin level are poorly known. Nevertheless, several proposed explanations include: elevated protein turnover, activated substrate cycle, increased gluconeogenesis, and sympathetic nervous system activity, all potentially caused by hyperinsulinemia [82].
Considering the strengths of the current study, to our knowledge, this study evaluated the relationship between appetite and related hormones with RMR in obese/overweight women by matching two important confounders, age, and BMI for the first time. Moreover, RMR was measured by indirect calorimetry, which is considered as the gold standard for measuring energy expenditure [3]. Also, all participants were examined when they were in the follicular phase, thus reducing the likelihood of the menstrual cycle impacting our results [38, 39]. In addition, we measured each participant's appetite, body composition, and physical activity using established and validated methods. Several limitations in our study should be noted. In the present study, no causal inferences could be drawn owing to the case–control design. Furthermore, the study only looked at overweight/obese women, it would be better to also have a normal weight control group to compare the RMR result, and while we matched cases and controls by age and BMI, there could be some other factors that skewed or confounded our results. Additionally, we used FFQ to record dietary intakes, and reported values from FFQ are subject to substantial errors. However we tried to minimize these problems with the help of experts, and questionnaires were completed in the presence of a trained nutritionist. Although the sample size was similar to that of earlier studies [36], and we calculated the needed sample size to detect the relationship between RMR and related hormones, it would be better to have a larger sample size.
Conclusion
In conclusion, the results of this study showed that there is a significant positive relationship between insulin levels and appetite sensation with RMR in the study population. No association was found between leptin levels and RMR. And a negative association between ghrelin levels with RMR in the “hypometabolic” group. Although speculative, it seems that serum ghrelin levels may play a role in the regulation of energy homeostasis by intervening endogenously to improve the state of impaired energy balance and increase energy efficiency.
Availability of data and materials
The authors confirm that the data supporting the findings of this study are available within the manuscript and in the included tables.
Abbreviations
- AG:
-
Acylated ghrelin
- BFM:
-
Body Fat Mass
- BIA:
-
Bioelectrical Impedance Analysis
- BMI:
-
Body Mass Index
- CV:
-
Coefficients of variation
- EE:
-
Energy Expenditure
- FFQ:
-
Food frequency questionnaire
- FFM:
-
Fat-Free Mass
- FM:
-
Fat Mass
- IPAQ:
-
International Physical Activity Questionnaires
- RMR:
-
Resting Metabolic Rate
- REE:
-
Resting Energy Expenditure
- UAG:
-
Unacylated ghrelin
References
Taheri F, Kazemi T, Chahkandi T, Namakin K, ZARDAST M, Bijari B. Prevalence of overweight, obesity and central obesity among elementary school children in Birjand, east of Iran, 2012. 2013.
Morton G, Cummings D, Baskin D, Barsh G, Schwartz M. Central nervous system control of food intake and body weight. Nature. 2006;443(7109):289–95.
Pinheiro Volp A, de Oliveira F, Duarte Moreira Alves R, Esteves E, Bressan J. Energy expenditure: components and evaluation methods. Nutricion hospitalaria. 2011;26(3).
Svendsen OL, Hassager C, Christiansen C. Impact of regional and total body composition and hormones on resting energy expenditure in overweight postmenopausal women. Metabolism. 1993;42(12):1588–91.
Bouchard C, Tremblay A, Nadeau A, Despres J, Theriault G, Boulay M, et al. Genetic effect in resting and exercise metabolic rates. Metabolism. 1989;38(4):364–70.
Fukagawa NK, Bandini LG, Young JB. Effect of age on body composition and resting metabolic rate. American Journal of Physiology-Endocrinology and Metabolism. 1990;259(2):E233–8.
Arciero PJ, Goran MI, Poehlman ET. Resting metabolic rate is lower in women than in men. J Appl Physiol. 1993;75(6):2514–20.
Johnstone AM, Murison SD, Duncan JS, Rance KA, Speakman JR. Factors influencing variation in basal metabolic rate include fat-free mass, fat mass, age, and circulating thyroxine but not sex, circulating leptin, or triiodothyronine. Am J Clin Nutr. 2005;82(5):941–8.
Caudwell P, Finlayson G, Gibbons C, Hopkins M, King N, Näslund E, et al. Resting metabolic rate is associated with hunger, self-determined meal size, and daily energy intake and may represent a marker for appetite. Am J Clin Nutr. 2013;97(1):7–14.
Blundell JE, Caudwell P, Gibbons C, Hopkins M, Naslund E, King N, et al. Role of resting metabolic rate and energy expenditure in hunger and appetite control: a new formulation. Dis Model Mech. 2012;5(5):608–13.
Blundell JE, Caudwell P, Gibbons C, Hopkins M, Näslund E, King NA, et al. Body composition and appetite: fat-free mass (but not fat mass or BMI) is positively associated with self-determined meal size and daily energy intake in humans. Br J Nutr. 2012;107(3):445–9.
Druce MR, Small CJ, Bloom SR. Minireview: gut peptides regulating satiety. Endocrinology. 2004;145(6):2660–5.
Wren A, Seal L, Cohen M, Brynes A, Frost G, Murphy K, et al. Ghrelin enhances appetite and increases food intake in humans. 2001.
Broglio F, Arvat E, Benso A, Gottero C, Muccioli G, Papotti M, et al. Ghrelin, a natural GH secretagogue produced by the stomach, induces hyperglycemia and reduces insulin secretion in humans. The Journal of Clinical Endocrinology & Metabolism. 2001;86(10):5083.
Tschöp M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature. 2000;407(6806):908–13.
Stevanovic DM, Grefhorst A, Themmen AP, Popovic V, Holstege J, Haasdijk E, et al. Unacylated ghrelin suppresses ghrelin-induced neuronal activity in the hypothalamus and brainstem of male rats. PLoS ONE. 2014;9(5): e98180.
Delhanty PJ, Huisman M, Baldeon-Rojas LY, van den Berge I, Grefhorst A, Abribat T, et al. Des-acyl ghrelin analogs prevent high-fat-diet-induced dysregulation of glucose homeostasis. FASEB J. 2013;27(4):1690–700.
Toshinai K, Yamaguchi H, Sun Y, Smith RG, Yamanaka A, Sakurai T, et al. Des-acyl ghrelin induces food intake by a mechanism independent of the growth hormone secretagogue receptor. Endocrinology. 2006;147(5):2306–14.
Delhanty PJ, Neggers SJ, van der Lely AJ. Mechanisms in endocrinology: Ghrelin: the differences between acyl-and des-acyl ghrelin. Eur J Endocrinol. 2012;167(5):601–8.
Stylianou C, Galli-Tsinopoulou A, Farmakiotis D, Rousso I, Karamouzis M, Koliakos G, et al. Ghrelin and leptin levels in obese adolescents. Relationship with body fat and insulin resistance. Hormones-Athens. 2007;6(4):295.
Cummings DE, Foster KE. Ghrelin-leptin tango in body-weight regulation. Gastroenterology. 2003;124(5):1532–5.
Churm R, Davies J, Stephens J, Prior S. Ghrelin function in human obesity and type 2 diabetes: a concise review. Obes Rev. 2017;18(2):140–8.
Klok MD, Jakobsdottir S, Drent M. The role of leptin and ghrelin in the regulation of food intake and body weight in humans: a review. Obes Rev. 2007;8(1):21–34.
Colombo M, Gregersen S, Xiao J, Hermansen K. Effects of ghrelin and other neuropeptides (CART, MCH, orexin A and B, and GLP-1) on the release of insulin from isolated rat islets. Pancreas. 2003;27(2):161–6.
Cui H, López M, Rahmouni K. The cellular and molecular bases of leptin and ghrelin resistance in obesity. Nat Rev Endocrinol. 2017;13(6):338–51.
Meier U, Gressner AM. Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin Chem. 2004;50(9):1511–25.
Park H-K, Ahima RS. Physiology of leptin: energy homeostasis, neuroendocrine function and metabolism. Metabolism. 2015;64(1):24–34.
Nicklas BJ, Toth MJ, Poehlman ET. Daily energy expenditure is related to plasma leptin concentrations in older African-American women but not men. Diabetes. 1997;46(9):1389–92.
Jørgensen JO, Vahl N, Dall R, Christiansen JS. Resting metabolic rate in healthy adults: relation to growth hormone status and leptin levels. Metabolism. 1998;47(9):1134–9.
Roberts SB, Nicholson M, Staten M, Dallal GE, Sawaya AL, Heyman MB, et al. Relationship between circulating leptin and energy expenditure in adult men and women aged 18 years to 81 years. Obes Res. 1997;5(5):459–63.
Arslanian S, Suprasongsin C, Kalhan SC, Drash AL, Brna R, Janosky JE. Plasma leptin in children: relationship to puberty, gender, body composition, insulin sensitivity, and energy expenditure. Metabolism. 1998;47(3):309–12.
Kennedy A, Gettys TW, Watson P, Wallace P, Ganaway E, Pan Q, et al. The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure. J Clin Endocrinol Metab. 1997;82(4):1293–300.
Salbe AD, Nicolson M, Ravussin E. Total energy expenditure and the level of physical activity correlate with plasma leptin concentrations in five-year-old children. J Clin Investig. 1997;99(4):592–5.
Smeets AJ, Westerterp-Plantenga MS. Acute effects on metabolism and appetite profile of one meal difference in the lower range of meal frequency. Br J Nutr. 2008;99(6):1316–21.
Johnson KO, Holliday A, Mistry N, Cunniffe A, Howard K, Stanger N, et al. An increase in fat-free mass is associated with higher appetite and energy intake in older adults: a randomised control trial. Nutrients. 2021;13(1):141.
Marzullo P, Verti B, Savia G, Walker GE, Guzzaloni G, Tagliaferri M, et al. The Relationship between Active Ghrelin Levels and Human Obesity Involves Alterations in Resting Energy Expenditure. J Clin Endocrinol Metab. 2004;89(2):936–9.
Brehm M-A, Harlaar J, Groepenhof H. Validation of the portable VmaxST system for oxygen-uptake measurement. Gait Posture. 2004;20(1):67–73.
Meijer G, Westerterp KR, Saris W, ten Hoor F. Sleeping metabolic rate in relation to body composition and the menstrual cycle. Am J Clin Nutr. 1992;55(3):637–40.
Benton MJ, Hutchins AM, Dawes JJ. Effect of menstrual cycle on resting metabolism: A systematic review and meta-analysis. PLoS ONE. 2020;15(7): e0236025.
Vogler AJ, Rice AJ, Gore CJ. Validity and reliability of the Cortex MetaMax3B portable metabolic system. J Sports Sci. 2010;28(7):733–42.
Prieur F, Castells J, Denis C. A methodology to assess the accuracy of a portable metabolic system (VmaxST). Med Sci Sports Exerc. 2003;35(5):879–85.
Flancbaum L, Choban PS, Bradley LR, Burge JC. Changes in measured resting energy expenditure after Roux-en-Y gastric bypass for clinically severe obesity. Surgery. 1997;122(5):943–9.
Shaneshin M, Rezazadeh A, Jessri M, Neyestani T, Rashidkhani B. Validity of predictive equations for resting energy expenditure among Iranian women. Asia Pac J Clin Nutr. 2011;20(4):646.
Kyle UG, Bosaeus I, De Lorenzo AD, Deurenberg P, Elia M, Gómez JM, et al. Bioelectrical impedance analysis—part II: utilization in clinical practice. Clin Nutr. 2004;23(6):1430–53.
Mirmiran P, Esfahani FH, Mehrabi Y, Hedayati M, Azizi F. Reliability and relative validity of an FFQ for nutrients in the Tehran lipid and glucose study. Public Health Nutr. 2010;13(5):654–62.
Ghaffarpour M, Houshiar-Rad A, Kianfar H. The manual for household measures, cooking yields factors and edible portion of foods. Tehran: Nashre Olume Keshavarzy. 1999;7(213):42–58.
Moghaddam MB, Aghdam FB, Jafarabadi MA, Allahverdipour H, Nikookheslat SD, Safarpour S. The Iranian Version of International Physical Activity Questionnaire (IPAQ) in Iran: content and construct validity, factor structure, internal consistency and stability. World Appl Sci J. 2012;18(8):1073–80.
Flint A, Raben A, Blundell J, Astrup A. Reproducibility, power and validity of visual analogue scales in assessment of appetite sensations in single test meal studies. Int J Obes. 2000;24(1):38–48.
Hill A, Rogers P, Blundell J. Techniques for the experimental measurement of human eating behaviour and food intake: a practical guide. International journal of obesity and related metabolic disorders: journal of the International Association for the Study of Obesity. 1995;19(6):361–75.
Blundell J, De Graaf C, Hulshof T, Jebb S, Livingstone B, Lluch A, et al. Appetite control: methodological aspects of the evaluation of foods. Obes Rev. 2010;11(3):251–70.
MacKenzie-Shalders K, Kelly JT, So D, Coffey VG, Byrne NM. The effect of exercise interventions on resting metabolic rate: A systematic review and meta-analysis. J Sports Sci. 2020;38(14):1635–49.
Blundell J, Gibbons C, Caudwell P, Finlayson G, Hopkins M. Appetite control and energy balance: impact of exercise. Obes Rev. 2015;16:67–76.
Mohammadpour S, Ghorbaninejad P, Shahinfar H, Ebaditabar M, Babaei N, Davarzani S, et al. The low-carbohydrate-diet score is associated with resting metabolic rate: an epidemiologic study among Iranian adults. Journal of Diabetes & Metabolic Disorders. 2021:1–9.
Ebbeling CB, Feldman HA, Klein GL, Wong JM, Bielak L, Steltz SK, et al. Effects of a low carbohydrate diet on energy expenditure during weight loss maintenance: randomized trial. bmj. 2018;363.
Grannell A, Al-Najim W, Mangan A, Kapoor N, Martin WP, Murphy JC, et al. Fat free mass is positively associated with hunger and energy intake at extremes of obesity. Appetite. 2019;143: 104444.
Weise CM, Hohenadel MG, Krakoff J, Votruba SB. Body composition and energy expenditure predict ad-libitum food and macronutrient intake in humans. Int J Obes. 2014;38(2):243–51.
Stubbs RJ, Hopkins M, Finlayson G, Duarte C, Gibbons C, Blundell J. Potential effects of fat mass and fat-free mass on energy intake in different states of energy balance. Eur J Clin Nutr. 2018;72(5):698–709.
Pandit R, Beerens S, Adan RA. Role of leptin in energy expenditure: the hypothalamic perspective. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 2017;312(6):R938–47.
Neuhauser-Berthold M, Herbert BM, Luhrmann PM, Sultemeier AA, Blum WF, Frey J, et al. Resting metabolic rate, body composition, and serum leptin concentrations in a free-living elderly population. Eur J Endocrinol. 2000;142(5):486–92.
Campostano A, Grillo G, Bessarione D, De Grandi R, Adami G. Relationships of serum leptin to body composition and resting energy expenditure. Horm Metab Res. 1998;30(10):646–7.
Hukshorn CJ, Saris WH. Leptin and energy expenditure. Curr Opin Clin Nutr Metab Care. 2004;7(6):629–33.
Chrysafi P, Perakakis N, Farr OM, Stefanakis K, Peradze N, Sala-Vila A, et al. Leptin alters energy intake and fat mass but not energy expenditure in lean subjects. Nat Commun. 2020;11(1):5145.
Niskanen L, Haffner S, Karhunen L, Turpeinen A, Miettinen H, Uusitupa M. Serum leptin in relation to resting energy expenditure and fuel metabolism in obese subjects. Int J Obes. 1997;21(4):309–13.
Kaiyala KJ, Schwartz MW. Toward a more complete (and less controversial) understanding of energy expenditure and its role in obesity pathogenesis. Diabetes. 2011;60(1):17–23.
Shah N, Dogar M, Vittorio T. The role of neurohormonal imbalances in obesity. Adv Obes Weight Manag Control. 2017;7:182–3.
Jalilian N, Haghnazari L, Rasolinia S. Leptin and body mass index in polycystic ovary syndrome. Indian journal of endocrinology and metabolism. 2016;20(3):324.
Wortley KE, Anderson KD, Garcia K, Murray JD, Malinova L, Liu R, et al. Genetic deletion of ghrelin does not decrease food intake but influences metabolic fuel preference. Proc Natl Acad Sci. 2004;101(21):8227–32.
Casanueva FF, Dieguez C. Ghrelin: the link connecting growth with metabolism and energy homeostasis. Rev Endocr Metab Disord. 2002;3(4):325–38.
Druce M, Bloom SR. Central regulators of food intake. Curr Opin Clin Nutr Metab Care. 2003;6(4):361–7.
Horvath TL, Diano S, Sotonyi P, Heiman M, Tschöp M. Minireview: ghrelin and the regulation of energy balance—a hypothalamic perspective. Endocrinology. 2001;142(10):4163–9.
Inui A. Ghrelin: an orexigenic and somatotrophic signal from the stomach. Nat Rev Neurosci. 2001;2(8):551–60.
Sainsbury A, Cooney GJ, Herzog H. Hypothalamic regulation of energy homeostasis. Best Pract Res Clin Endocrinol Metab. 2002;16(4):623–37.
St-Pierre DH, Wang L, Taché Y. Ghrelin: a novel player in the gut-brain regulation of growth hormone and energy balance. Physiology. 2003;18(6):242–6.
Lv Y, Liang T, Wang G, Li Z. Ghrelin, a gastrointestinal hormone, regulates energy balance and lipid metabolism. Bioscience reports. 2018;38(5).
St-Pierre DH, Karelis AD, Cianflone K, Conus F, Mignault D, Rabasa-Lhoret R, et al. Relationship between ghrelin and energy expenditure in healthy young women. J Clin Endocrinol Metab. 2004;89(12):5993–7.
Bagnasco M, Dube M, Kalra P, Kalra S. Evidence for the existence of distinct central appetite, energy expenditure, and ghrelin stimulation pathways as revealed by hypothalamic site-specific leptin gene therapy. Endocrinology. 2002;143(11):4409–21.
Drabsch T, Holzapfel C, Stecher L, Petzold J, Skurk T, Hauner H. Associations Between C-Reactive Protein, Insulin Sensitivity, and Resting Metabolic Rate in Adults: A Mediator Analysis. Frontiers in Endocrinology. 2018;9(556).
Huang KC, Kormas N, Steinbeck K, Loughnan G, Caterson ID. Resting metabolic rate in severely obese diabetic and nondiabetic subjects. Obes Res. 2004;12(5):840–5.
Hou JC, Min L, Pessin JE. Insulin granule biogenesis, trafficking and exocytosis. Vitam Horm. 2009;80:473–506.
Petersen MC, Shulman GI. Mechanisms of insulin action and insulin resistance. Physiol Rev. 2018;98(4):2133–223.
Ravussin E, Bogardus C, Schwartz R, Robbins D, Wolfe R, Horton E, et al. Thermic effect of infused glucose and insulin in man. Decreased response with increased insulin resistance in obesity and noninsulin-dependent diabetes mellitus. The Journal of clinical investigation. 1983;72(3):893–902.
Bitz C, Toubro S, Larsen TM, Harder H, Rennie KL, Jebb SA, et al. Increased 24-h energy expenditure in type 2 diabetes. Diabetes Care. 2004;27(10):2416–21.
Acknowledgements
The authors would like to thank the participants for their kind cooperation.
Funding
The research is financially supported by the Tehran University of Medical sciences.
Author information
Authors and Affiliations
Contributions
KM, HI designed the study. SH and SM contributed to the literature searches, data collection, and measurements. SY and SH contributed to the statistical analyses and interpretation of the data, SH drafted the manuscript. KM, CCTC, SH and AM critically revised the manuscript; and agree to be fully accountable for ensuring the integrity and accuracy of the work. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethical approval and consent to participate
The study protocol was approved by the Ethics Commission of Tehran University of Medical Sciences (IR.TUMS.MEDICINE.REC.1399.261). Then, written informed consent was obtained from all patients. All methods were performed in accordance with the declaration of Helsinki.
Consent for publication
Not applicable.
Competing interest
The authors declare no potential conflict of interest with respect to the research, authorship, and/or publication of this article.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Hajishizari, S., Imani, H., Mehranfar, S. et al. The association of appetite and hormones (leptin, ghrelin, and Insulin) with resting metabolic rate in overweight/ obese women: a case–control study. BMC Nutr 8, 37 (2022). https://doi.org/10.1186/s40795-022-00531-w
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s40795-022-00531-w